|
Real-time Estimate
Cboe BZX
10:27:38 05/11/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 62.36 USD | -4.84% |
|
+0.62% | +58.92% |
| 04/11 | Needham Raises Price Target on AtriCure to $70 From $64, Keeps Buy Rating | MT |
| 04/11 | AtriCure, Inc., Q3 2026 Earnings Call, Nov 03, 2026 |
Company Valuation: AtriCure, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 3,194 | 2,064 | 1,692 | 1,490 | 1,967 | 3,333 | - | - |
| Change | - | -35.37% | -18.05% | -11.92% | 32.01% | 69.48% | - | - |
| Enterprise Value (EV) 1 | 3,210 | 2,063 | 1,623 | 1,441 | 1,873 | 3,165 | 3,104 | 3,007 |
| Change | - | -35.73% | -21.32% | -11.21% | 29.97% | 69.02% | -1.93% | -3.12% |
| P/E | 63.8x | -43.5x | -54.1x | -32.2x | -165x | 614x | 159x | 96x |
| PBR | 6.61x | 4.52x | 3.55x | 3.24x | 4x | 5.78x | 5.13x | 4.48x |
| PEG | - | 0x | 1.5x | -0.7x | 2.2x | -4x | 1x | 1.5x |
| Capitalization / Revenue | 11.6x | 6.25x | 4.24x | 3.2x | 3.68x | 5.5x | 4.9x | 4.35x |
| EV / Revenue | 11.7x | 6.24x | 4.06x | 3.1x | 3.5x | 5.22x | 4.56x | 3.93x |
| EV / EBITDA | -366x | -943x | 83.5x | 46.3x | 30.3x | 35.3x | 30.4x | 24.1x |
| EV / EBIT | -67.9x | -48.3x | -60.8x | -36x | -198x | 305x | 138x | 80.8x |
| EV / FCF | -136x | -52.9x | -216x | 1,934x | 38.8x | 60.1x | 76.5x | - |
| FCF Yield | -0.73% | -1.89% | -0.46% | 0.05% | 2.58% | 1.66% | 1.31% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.09 | -1.02 | -0.66 | -0.95 | -0.24 | 0.1067 | 0.4129 | 0.6828 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 274.3 | 330.4 | 399.2 | 465.3 | 534.5 | 606.3 | 680.5 | 765.5 |
| EBITDA 1 | -8.776 | -2.188 | 19.45 | 31.12 | 61.77 | 89.58 | 102.1 | 124.9 |
| EBIT 1 | -47.3 | -42.67 | -26.68 | -40.01 | -9.447 | 10.38 | 22.52 | 37.24 |
| Net income 1 | 50.2 | -46.47 | -34.85 | -44.7 | -11.45 | 6.506 | 18.97 | 31.27 |
| Net Debt 1 | 16.09 | -1.265 | -68.63 | -49 | -94.05 | -168 | -229.1 | -325.8 |
| Reference price 2 | 69.53 | 44.38 | 35.69 | 30.56 | 39.56 | 65.53 | 65.53 | 65.53 |
| Nbr of stocks (in thousands) | 45,932 | 46,508 | 47,395 | 48,753 | 49,717 | 50,866 | - | - |
| Announcement Date | 15/02/22 | 21/02/23 | 15/02/24 | 12/02/25 | 17/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 614.32x | 5.22x | 35.34x | -.--% | 333.33Cr | |
| 38.21x | 4.47x | 16.8x | 2.25% | 20TCr | |
| 22.72x | 3.84x | 13.74x | 2.7% | 13TCr | |
| 29.15x | 5.18x | 17.71x | 1.07% | 13TCr | |
| 33.19x | 3.18x | 12.84x | 2.15% | 9.75TCr | |
| 18.78x | 0.22x | 13.95x | 0.67% | 6.76TCr | |
| 42.64x | 3.78x | 12.86x | 2% | 5.7TCr | |
| 47.01x | 11.64x | 32.68x | -.--% | 5.5TCr | |
| 29.36x | 7.27x | 18.57x | 1.38% | 5.12TCr | |
| 45.89x | 3.62x | 13.43x | 0.48% | 3.74TCr | |
| Average | 92.13x | 4.84x | 18.79x | 1.27% | 8.27TCr | |
| Weighted average by Cap. | 35.22x | 4.55x | 16.59x | 1.68% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ATRC Stock
- Valuation AtriCure, Inc.
Select your edition
All financial news and data tailored to specific country editions
